schmitt adolescent diabetes (read-only)

10
8/11/16 1 Adolescents With Diabetes: Improving the Numbers Terri Schmitt PhD, ARNP, FNP-BC, CDE Pediatric Endocrine and Diabetes, Palm Beach Gardens, FL Associate Professor, Chamberlain College of Nursing Objectives Review differences in Type 1 and Type 2 diabetes in adolescents. Review physical and psychosocial developmental factors specific to adolescents affecting diabetes disease management. Identify risks specific to the adolescent with diabetes that may contribute to poor health outcomes. Identify provider actions and current treatment modalities that may benefit the adolescent patient with diabetes. Review medication management of Type 1 and Type 2 diabetes in adolescents 2 Adolescence You don't have to suffer to be a poet; adolescence is enough suffering for anyone. --- John Ciardi “All my life I've felt like there was something wrong with me. Something missing or damaged… Every teenager in the world feels like that, feels broken or out of place, different somehow, royalty mistakenly born into a family of peasants.” Cassandra Clare, City of Bones 3 Adolescence Adolescence Period of rapid physical, emotional, cognitive, and social development Initiation 11-12 and completion 18-21 Western teens complete puberty by age 16-18 Passage of childhood to adulthood steps: Completing puberty and somatic growth Developing socially, emotionally, cognitively Abstract thinking Establishing independent identity Preparing for career/vocation 5 Type 1 Diabetes SEARCH Study UK Study Increase in autoimmune diseases Prevalence: 2001 – 1.48/1000, 2009 –1.93/1000.(21%) Highest Caucasians 2.55/1000 Increase in all age groups 6

Upload: others

Post on 23-Jun-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

1

Adolescents With Diabetes: Improving the Numbers

TerriSchmittPhD,ARNP,FNP-BC,CDEPediatricEndocrineandDiabetes,PalmBeachGardens,FL

AssociateProfessor,ChamberlainCollegeofNursing

Objectives• ReviewdifferencesinType1andType2diabetesinadolescents.

• Reviewphysicalandpsychosocialdevelopmentalfactorsspecifictoadolescentsaffectingdiabetesdiseasemanagement.

• Identifyrisksspecifictotheadolescentwithdiabetesthatmaycontributetopoorhealthoutcomes.

• Identifyprovideractionsandcurrenttreatmentmodalitiesthatmaybenefittheadolescentpatientwithdiabetes.

• ReviewmedicationmanagementofType1andType2diabetesinadolescents

2

AdolescenceYoudon't havetosuffertobeapoet;adolescenceisenoughsuffering foranyone.--- John Ciardi

“AllmylifeI'vefeltliketherewassomethingwrong withme.Something missingordamaged…Everyteenagerinthe world feelslikethat, feelsbrokenor outofplace, different somehow,royaltymistakenlyborn intoafamilyofpeasants.”

CassandraClare, City ofBones

3

Adolescence

Adolescence• Period ofrapid physical, emotional, cognitive,andsocial development

• Initiation 11-12andcompletion 18-21• Westernteens complete puberty byage16-18• Passageofchildhood toadulthood steps:– Completingpubertyandsomaticgrowth– Developingsocially,emotionally, cognitively– Abstractthinking– Establishingindependentidentity– Preparingforcareer/vocation

5

Type1Diabetes

• SEARCHStudy• UKStudy• Increaseinautoimmunediseases

• Prevalence:2001– 1.48/1000,2009– 1.93/1000.(21%)

• HighestCaucasians2.55/1000• Increaseinallagegroups

6

Page 2: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

2

Type2Diabetes

• Obesity• Increaseinnewcasesin1990’s,continuestoclimb

• Greaterburdeninminorities

• Currentresearch:SEARCH,HEALTHY,TODAY

7

OtherTypes

• MODY• Idiopathyic Diabetes• CysticFibrosis• Medication/treatment induced• Other exocrine pancreatic diseases

8

SEARCH

• Epidemiology totrackdiabetesin youth• Funded byCDC andNIDDK• Started 2000– continued through 2015• Lookedatincidence, prevalence, diabeteseducation, complications, treatment patterns

https://www.searchfordiabetes.org/public/dsphome.cfm

HEALTHY

• RCT• Middle Schools• Criteria: 50%minority, 50%reduced schoollunch• Fouraims: nutrition, physicalactivity, behavioralchange, communication

• Significant REDUCTION inobesityControl&Non-Control schools

• Control schools:decreased waist circumference &fasting insulin

www.healthystud y.org

TODAY

• TreatmentOptions forType2DiabetesinAdolescents andYouth• Metformin,Metformin +lifestyle,Metformin +Rosiglitazone• Inclusion: T2DM for2years,10-17 years• Outcome: time tolossof glycemic control, insulin

secretion/resistance, body composition, nutrition,physicalactivity,anddiabetes complications, cost,genetics

• Results: Complications https://portal.bsc.gwu.edu/web/today• DiabetesCare:

http://care.diabetesjournals.org/site/misc/todayseries.xhtml

TODAY

Page 3: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

3

TODAYInsulinSensitivity

Overall Control:%of youth(Hgb A1c> 9.5%)

Race T1DM T2DM

Caucasian 12.3% 12.2%

African-American 35.5% 22.3%

Hispanic 27.3% 27.4%

Asian/PacificIslander

26.0% 36.4%

NativeAmerican 52.2% 43.8%

14Petitti D, etal, 2009

AdolescentDiabetics

• Pubertal effects• Weightincreases• Movetomoreindependent management• Peerinfluences• Mediainfluences• Changeinlifestyles• Diet

Updates:StandardsforDiabetesCare2015

• BMIcut-off forAsianAmericans forDiabetesscreening decreased to23kg/m2

• Limit sedentary timetono>90minsitting• Pre-meal glycemic target80-130 mg/dl• Newstandards forassessingCGMreadiness• Diastolic 90mmHg• Statin treatment nowbyrisk,notLDL• InChildren/Adolescents Hgb A1cTarget7.5%or>

Updates:StandardsforDiabetesCare2016

• Taking theterm ‘diabetic’outtorefertopatients

• Noonetestfordiagnosisispreferred• Encouragingtheuseofappsandtechnologyformanagement

Updates:2016KidSpecific T1DM• Mental health consideration: diabetes distress, fearofhypoglycemia/hyperglycemia, anxiety, disorderedeating behaviors, depression

• GOALS: Before meals – 90-130Bedtime 90-150,,A1c<7.5%,7.0% isreasonable ifitcanbeachieved.

• Screen forotherautoimmune disorders inT1DM,soonafter diagnosis (Thyroid, celiac)

• B/Pscreening - >90%systolicor>95% (HTN)havebloodpressureconfirmed on3separate days

• Lipids– Inchildren anLDL<100screen every 3-5yrs

Page 4: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

4

Updates:2016KidSpecific T2DM

• Incidence projected toquadruple inthenext40years

• Obesitymakesdistinguishing typedifficult(T2DMcanpresent withketoacidosis)

• Onlyoral medication approved isMetformin• Sametreatment goals

Diabetesinkids

• Unfortunately– lackofclinicaltrialevidence inchildren

• Childrenatriskforhypoandhyperglycemiadueto:– PhysiologicGrowthanddevelopment– Medicationsensitivity– Self-careneeds– Environment– FamilyDynamics– Peerrelationships– Developmentalneeds

HemoglobinA1cCorrelationtoBloodGlucose

Hgb A1c% Avg.Bld Glucose6% 1357% 1708% 2049% 24010% 27511% 31012% 35013% 386

T1DM:NewOnset• Polyuria,polydipsea, polyphagia,

weightloss• Lab:

– Glucosefasting>,PP>– Hgb A1C>6.5%– Fastinginsulin- >126mg/dL– C-Peptide*Antibodies(Panel)– Isletcellcytoplasmicautoantibodies (ICA)

– Glutamic aciddecarboxylaseautoantibodies (GADA)

– Insulinoma-associated-2autoantibodies (IA-2A)

– Insulinautoantibodies (IAA)

• Ensure norecent steroid,othermeds

• PediatricEndocrinologyconsult

• DiabetesEducation:– Monitoring– Insulinadministration(storage, mixing,optionsfordelivery)

– Meals– Preventive education– Illnessmanagement

22

Case1• Lindsey- 16y/oCaucasian T1DMfemalewho isasophomore. ShehashadT1DMsinceage10

• Current insulin Regimen:Lantus 95units atHS,Humalog tocarbohydrate ratio atmeals1:5.Correction is(BG-100)/50.

• Problem: Sherefusestoseetheschool nurseprior tolunch forglycemicchecks.Oftenskipslunch. Hgb A1catvisitsisrunning 10-13%.Whenher blood sugarismonitored herlevelsarerunning 200-300mg/dl. Testing1-2times/day.

23

CriteriaforDiagnosisofDiabetes

2015Standards ofDiabetes CareA1C≥6.5%

OR

FPG≥126mg/dL

OR

2 HRPP ≥200mg/dL

ORPts w/signsofhyperglycemia-randomplasma

glucose≥200mg/dL

Page 5: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

5

T1DM:Adolescents-WorseningControl• Almost2/3’sofadolescentswithT1DMdon’tmeettreatmentgoals

• Poormanagement• Insulinomission(intentionalvs.unintentional)

• Lackofmonitoring• Diet(grazing,notmeasuring,notconsistent)

• Support,home,family• Howdoesthatmakeyoufeel?

• Longerdiabetes• Non-Caucasian• Unmarriedcaregivers• Injections• Depression• Negativeattitudeofmonitoring

• Income

25

T1DM:EffectsofPubertyonInsulin

• DCCT – worsecontrol than adults• Insulin Resistance: GHandIGF-1– Insulinsensitivitydeclines25%to30%– Decreaseinsulinreleasebypancreases

• Luteal phasehyperglycemia• Irregular menses

26

T1DM:TheImportanceofFamily

BETTERMANAGEMENT• greaterparentalinvolvement

• monitoring• responsibility-sharing• lower familyconflict• greatercoping,self-regulation,includingproblem-solving

ASINTERVENTION• FACTS research

FAMILYSTRESS

27

T1DM:InsulinOmission– DisorderedEating

• Even infrequent increases riskofneg health outcomes• Insulinomissionunique/frequent (rates 7.4%-74%)

• Thoseat risk fororengaging inDEBs generally scorewithin ‘normal’

• T1DMadolescents without DEBs - lessdepression,better body image, andhigher self-esteem Importanthealth problem

• Difficult toidentify girlsat riskwithgeneralpsychometric measures

• Nolarge scaleprevention interventions todate 28

Media T1DM:Alcohol

• ADA– Adultsnomorethan2• HypoglycemiaSymptomsMimicIntoxication

• Delayedhepaticresponse

Page 6: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

6

T1DM:AlternativesforTreatment

• MDI• Continuous insulin infusion• Closed loop insulin therapy• Pramlitidine• Metformin inobesity• TDD• Basal60%:Bolus 40%• RisksofContinuous infusion• Backtomanagement

31

T1DM:AlternativesforMonitoring

• Monitoring:AC,HS,Pre-driving,pre-exercise,2hourPost-Prandial

• CGM• Glucosewatch• iPhone bloodglucosemonitors

• Glucosetrackingapps

32

T1DM:CGM T1DM:PumpsANIMASVIBE

MEDTROINIC530g

T-SLIM

ASANTESNAP

T1DMP:PumpsOMNIPOD

Onset,Peak,DurationINSULIN1 ONSET PEAK DURATIONHumalog (lLspro) 5-10min 1-2hrs 3-4hrs

Novolog (Aspart) 5-10min 1-2hrs 3-4hrs

Apidra (Glulisine) <15min 1-2hrs 3-6hrs

Novolin R/Humulin R 30-60min 2-4hrs 6hrs

Novolin N/Humulin N 2-4hrs 4-8hrs 10-15hrs

Lantus (Galargine) 1-2hrs Nopeak 24hours

Levemir (Detemir) 1-2hrs Nopeak* Upto24hrs

Page 7: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

7

Case1Lindsey• Follow upintheoffice:–Workwith,notagainstherandfamily.– Gotoher?Howcanwefacilitateinsteadofpunish?– Evaluate familyfunctioning– Involveherasleader– Healthychoicesatschool(exerciseanddiet)– Heroutsideschoolinvolvement– Keepparentsinformed–Workwithherprimarycareprovider– Beflexible

Case2• Steven isa12y/omiddleschoolerrecentlydiagnosedwithT1DM

• PlacedonNPHandHumalogtwicedailywithacorrectiondoseslidingscaleof1unitofHumalogbeforemealsforevery100over200.

• Problem:Hisparentsareseparatedandmotherisoverlyprotective.Shecallstheschooleverydayatlunchtofindouthisbloodsugaranddisparagesthecarefatherprovides.Stevenisin‘honeymoon’andhasbeenhavingbloodsugarsof65-70priortolunch,evenwithdecreasingdosing.

Hypoglycemiamanagement

• Ruleof15’s• 70to80???What’syourrange?• Sendtolunchifaboveyourruleorfollowwithprotein+carbohydratesnack

• Havechildrenwalkedtotheoffice• Discernreason– PE,activity,decreasedfoodintake,honeymoon,incorrectdose?

Case2:Howcanwehelp

• Bepositive• Be flexible• Involve schoolcounselor andteacher• Family counseling• Encourage thechild• Relationship with endocrinologist/primary careprovider

• Help thechildwithgrowing independence• Setupacontract withmom, affirm her fears,reassure her butspend time now

Case3• Michael- 15y/oblackHaitian malediagnosedlastyear,afterahospitalization andinitialinsulin 75/25start, withT2DM.

• Physical importance: B/P140/88, BMI39,acanthosis ofneck

• Problems:Hehasbeenplaced onMetforminathomeBID.Blood glucose monitoring israndom andthere havebeennodiet changesathome.Hehashadpoor follow up.

• Lab:Hgb A1c10%,Vit D25OH13,FastingInsulin 40 41

Diagnosing

• SameADAcriteria• Noantibodies• Makinginsulin (C-peptide)• PhysicalExam:signsofhyperinsulinemia,central adipose deposition, ‘buffalo hump’,fusiform fingers, striae, irregular menses

• MissingType1inanobesechild

42

Page 8: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

8

T2DM:RiskFactors• Obesity• Genetics/ +FamilyHistory• Ethnicity• Maternaldiabetes during

pregnancy +maternalobesity• Puberty• Diet,glycemic response, types of

foods• Low vitaminD(25-OH <25)• Fructose• Sleep• Stress/cortisol• PCOS

43

T2DM:Longterm

• Monitor, Meals,Movement, Management,Medications

• Diabetes Education• Pediatric Endocrinologist• Better control with insulin?• Monitor for complications• FamilyInvolvement• Inflammation

44

T2DM:Diet,Diet,Diet

• Decreased Calorie Intake• Processed carbohydrate consumption• Lower Glycemic load• Portion sizes• Flavinoids• Protein forblood glucose stabilization

45

Problems?

T2DM:Who’smoving?

• Adolescentsstopmoving• AAP=1hourperday• Exerciseimprovescardiovascularoutcomes

• Increasingmusclemass• Hardexercise• Shortbursts• Family

47

T2DM:FamilySupport

• Diseaseofthefamily• Parents orgrandparents with poor control• Familydiabetes education• InvolvementinDiabetes groups• Sometimes nottakenasseriously

48

Page 9: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

9

T2DM:Treatment

Metformin – 500mgQD.Canincreasetomax1000mgBID.

InsulinRadical lifestylechangesExerciseVitamin D310,000 to50,000IUperweek

49

ImprovingtheNumbers• Reduced wait timesforcare• Reduce economic burden (lossofwork/school)

• Improveretention• Useoftechnology• Not adult care• Specialists• Accesstocareforlow-income

Screening&TreatingComplications

• Hypertension– B/Pmeasured ateach visit– High>90th %,HTN >95%– Measure ontwodifferent days– HighNormal Initial:Diet,exercise,weightcontrol (3-6months only)

– Hypertension: ACEinhibitors– GoalB/P consistently <90%

Percentiles inchildren -http://www.nhlbi.nih.gov/files/docs/resources/heart/hbp_ped.pdf

Screening&TreatingComplications

• Dyslipidemia– Obtainsoonafterdiagnosis&glucosestabilization– Yearly ifabnormal,every5yearsifnormal– Initialtreatment: Glucosestabilization– Olderthan10years– Statin ifLDL>160,orif>130+1ormoreCVDriskfactor.

– Goal:LDL<100mg/dl.

Screening&TreatingComplications

• Nephropathy– Annualscreenforalbuminuria,randomalbumin-to-creatinine ratio(UACR)>5years

– NephropathyDx withatleast2UACR>30mg/g of2outof3urinesamplesover6monthswithgoodglycemic control

– Treatment ifUACR>30mg/g isACEinhibitor.Startlow(i.e. Lisinopril 5mg)

– Nephrologyconsult

Screening&TreatingComplications

• Obesity: Non-alcoholic fatty liver disease, sleepAPNEA

• LowVitamin D– <30– 2000 unitsperdayOTC, or50,000 IUweeklytoeveryotherweek(Replesta, Ergocalciferol)

• Depression– Screening recommended inpoor control– Depression 3timesmore common inyouthwithdiabetes

– Psychiatric specialtycare

Page 10: SCHMITT ADOLESCENT DIABETES (Read-Only)

8/11/16

10

Pre-Diabetes:DiagnosingADAGuidelines

FPG100- 125mg/dL

OR

2-hPG/75-gOGTT140 - 199mg/dL

OR

A1C5.7–6.4%

55

Pre-Diabetes:RiskFactors

• Sedentary• Obesity• Familymembers with T2DM• PhysicalExamFindings• Femaleswith PCOS• High-risk ethnicity

56

Resources

• National DiabetesEducation Programyourdiabetes.org

• 2015ADAManagementGuidelines -http://care.diabetesjournals.org/content/38/Supplement_1/S8.full

• JDRF– http://jdrf.org/• ADA- http://www.diabetes.org/

ReferencesAmericanDiabetesAssociation.Standardsof DiabetesCare.2015.Retrievedfrom-

http://care.diabetesjournals.org/content/38/Supplement_1BarataDS,etal. Theeffectof themenstrualcycleonglucosecontrolinwomenwithtype1diabetesevaluated

usingacontinuousglucosemonitoringsystemDiabetesCare.2013;36(5) :e70CopelandKC,SilversteinJ,MooreKR,Prazar GE,Raymer T,etal.Managementof NewlyDiagnosedType2

DiabetesMellitus(T2DM)inChildrenandAdolescents.Pediatrics.Feb2013;131(2):364-82HilliardME,WuYP,RauschJ,DolanLM,HoodKK.PredictorsofDeteriorationsinDiabetesManagementand

ControlinAdolescentsWithType1Diabetes.DiabetesEducator.2012Jul-Aug;38(4):562-79.doi:10.1177/0145721712445216.

InternationalSocietyforPediatricandAdolescentDiabetes.GlobalIDF/ISPADguielines fordiabetesinchildhoodandadolescence.2011.Retrievedfromhttp://www.idf .org/sites/default/f iles/Diabetes- in-Childhood-and-Adolescence-Guidelines.pdf

Livesey G,TaylorR,Livesy H,LiuS.Isthereadose-responserelationof dietaryglycemic loadtoriskoftype2diabetes?Meta-analysisof prospectivecohortstudies. AmJClin Nutr.2013;97(3) :584-596

Lim,E.L., Hollingsworth,K.G., Aribisala,B.S., Chen,M.J.,Mathers,J.C., Taylor,R.Reversalof type2diabetes:normalisation of betacellfunctioninassociationwithdecreasedpancreasandlivertriacylglycero.Diabetologia.2012;54(10) ,2506-2514.

Murphy,H.R.,etal."FamiliesandAdolescentsCommunicationandTeamworkStudy(FACTS)Group:Randomizedtrialof adiabetesself -managementeducationandfamilyteamworkinterventioninadolescentswithType1diabetes."DiabeticMed.2012;29(8):e249-54.

ReferencesNanselTR, IannottiRJ,LiuA. Clinic-IntegratedBehavioralInterventionforFamiliesof

YouthWithType1Diabetes:RandomizedClinicalTrial. Pediatrics. 2012;129(4):e866-e873doi:10.1542/peds.2011-2858

Raush, JR,Hood,KK, Delamater,A,Shrof Pendley,J,Rohan,JM,Reeves,G,Dolan,JL,Drotar,D.ChangesinTreatmentAdherenceandGlycemic ControlDuringtheTransitiontoAdolescenceinType1Diabetes.DiabetesCare.2012;35(6):1219-1224

Selvin E,SteffesMW,Ballantyne CM,HoogeveenRC,Coresh J,BrancatiFL.Racialdifferencesinglycemic markers:across-sectionalanalysisofcommunity-baseddata.Ann InternMed2011;154:303–309

SpringerSC,Silberstein J,CopelandK,etal. ManagementofType2DiabetesMellitusinChildrenandAdolescents. Pediatrics. 2013;131(2):e648-e664

SongY,WantL,PittasAG,DelGobboLC,ZhangC,MansonJE,HuFB.Blood25-HydroxyVitaminDLevelsandIncidentType2DiabetesAmeta-analysisofprospectivestudies. DiabetesCare, 2013,36(5):1422-1428

TfayliH,Arslanian S.Thechallengeofadolescence:hormonalchangesandsensitivitytoinsulin DiabetesVoice:BulletinoftheInternationalDiabetesFederation.2007;52:28–30

Whittmore R, Jaswer S,ChaoA,GreyM.Psychologicalexperienceofparentsofchildrenwith type1diabetes:asystematicmixed-studiesreview.2012;38(4):562-79.doi:10.1177/0145721712445216.

WilcoxG.Insulinandinsulin resistance.ClinicalBiochem Review.2005;26(2):19–39